Dthera Sciences

Nerve cells affected by Alzheimer's disease
Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursemen
By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.